Alanine
- Generic Name
- Alanine
- Brand Names
- Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Freamine 6.9, Freamine III 10, Hepatamine 8, Olimel, Periolimel, Plenamine, Premasol, Primene, Procalamine 3, Prosol, Travasol 10, Trophamine 10 %
- Drug Type
- Small Molecule
- Chemical Formula
- C3H7NO2
- CAS Number
- 56-41-7
- Unique Ingredient Identifier
- OF5P57N2ZX
- Background
Alanine is a non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and the central nervous system.
- Indication
Used for protein synthesis.
- Associated Therapies
- Amino acid supplementation
The Separate and Combined Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Subjects with and Without Type 1 Diabetes
Not Applicable
- Conditions
- Type 1 Diabetes
- Interventions
- Drug: Glucose-dependent Insulinotropic Polypeptide (GIP)Drug: Saline (NaCl 0,9 %) (placebo)
- First Posted Date
- 2025-03-18
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Asger Lund, MD
- Target Recruit Count
- 10
- Registration Number
- NCT06881472
- Locations
- 🇩🇰
Gentofte Hospital, Hellerup, Denmark
The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals
Phase 1
Recruiting
- Conditions
- Effect of iv Administration of GIP and Alanine
- Interventions
- First Posted Date
- 2024-05-17
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- University Hospital, Gentofte, Copenhagen
- Target Recruit Count
- 10
- Registration Number
- NCT06419686
- Locations
- 🇩🇰
Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup, Capital Region, Denmark
Effects of Alanine in Patients With Nonalcoholic Steatohepatitis
- First Posted Date
- 2008-01-07
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Keith D Lindor, M.D.
- Target Recruit Count
- 9
- Registration Number
- NCT00586885
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion
Not Applicable
- Conditions
- Infant, Low Birth WeightHyperglycemia
- First Posted Date
- 2000-06-05
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 96
- Registration Number
- NCT00005889
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath